|
시장보고서
상품코드
2131709
플라보포스폴리폴 시장 규모, 점유율, 성장 분석 : 형태별, 가축별, 용도별, 유통 채널별, 지역별 - 산업 예측(2026-2033년)Flavophospholipol Market Size, Share, and Growth Analysis, By Form (Powder, Premix), By Livestock (Poultry, Swine), By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 플라보포스폴리폴 시장 규모는 2024년에 1억 9,500만 달러로 평가되며, 2025년 2억 455만 달러에서 2033년까지 2억 9,993만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 4.9%로 성장할 것으로 전망되고 있습니다.
플라보포스폴리폴은 가축의 생산 효율과 질병 저항성을 높여 전 세계 동물 영양 시장의 성장을 촉진하는 중요한 항균성 사료첨가제입니다. 이러한 성장은 단백질이 풍부한 식품에 대한 소비자 수요 증가에 힘입은 것으로, 생산자들은 항생제 의존도를 낮추면서도 가축 군의 생산성을 향상시켜야 할 필요성에 직면해 있습니다. 특히 유럽연합(EU)의 규제 변화로 인해 기존의 성장 촉진제를 대체할 효과적인 대안으로서 플라보포스폴리폴의 채택이 증가하고 있습니다. 미국이나 브라질 등의 시장에서 돼지와 가금류를 위한 플라보포스폴리폴의 사용이 확대되고 있는 것은 식량안보 과제를 해결하는 데 있으며, 그 중요성을 여실히 보여주고 있습니다. 또한 이 첨가제가 널리 수용되고 있다는 사실은 사용이 금지된 항생제의 안전한 대체재로서의 입지를 공고히 하고, 생체 이용률 향상과 비용 절감을 도모하는 제형 기술의 혁신을 촉진하고 있습니다. 그 결과, 생산자들에게는 사료 전환율 향상과 수익성 증대가 이루어지고 있습니다.
전 세계 플라보포스폴리폴 시장의 성장 요인
항생제 내성에 대한 인식이 높아짐에 따라 축산 농가는 대체 성장 촉진제를 모색하고 있습니다. 플라보포스폴리폴은 제품의 안전성을 해치지 않으면서 동물의 건강을 증진시키는 효과적인 해결책으로 자리 잡고 있습니다. 이로 인해 가금류, 돼지, 소를 포함한 다양한 분야에서 수용이 촉진되고 있습니다. 수의사 및 사료 제조업체 사이에서 신뢰도가 높아짐에 따라 공급망내 협력이 강화되고 있으며, 플라보포스폴리폴을 포함한 사료첨가제의 배합이 증가하고 있습니다. 이러한 추세는 시장 침투를 촉진할 뿐만 아니라, 더 안전한 육류 제품을 원하는 소비자의 선호에도 부합하여 시장의 지속적인 성장을 지원하고, 장기적인 시장 확대에 기여하고 있습니다.
전 세계 플라보포스폴리폴 시장의 성장 저해 요인
전 세계 플라보포스폴리폴 시장에서 식품내 항생제 잔류물을 규제하기 위한 규제의 강화가 주요 제약 요인으로 작용하고 있습니다. 이러한 규제로 인해 감시가 더욱 엄격해지고 잔류 허용 한도가 낮아지게 되어, 결과적으로 생산자의 규정 준수 비용이 증가하고 있습니다. 이러한 규제는 특히 엄격한 제로 톨러런스 정책이 채택된 지역에서 사료에 첨가되는 플라보포스폴리폴의 양을 제한할 가능성이 있습니다. 그 결과, 많은 제조사들이 위험이 낮은 것으로 간주되는 대체 첨가제에 주목하고 있으며, 이는 시장 성장을 저해하고 전 세계 시장에서 플라보포스포리포롤의 보급을 지연시킬 가능성이 있습니다.
세계 플라보포스폴리폴 시장 동향
전 세계 플라보포스폴리폴 시장은 예방 영양의 추세에 힘입어 점점 더 성장하고 있습니다. 이는 각 제조사들이 치료용 항생제를 사용하지 않고도 질병 발생률을 낮추면서 사료 효율을 높이는 이 성분의 효능을 강조하고 있기 때문입니다. 이러한 노력은 항생제 적정 사용(항생제 스튜어드십)에 대한 업계의 노력에 부응하는 것이며, 지속가능한 농업 실천을 추구하는 농가의 요구와도 부합합니다. 사료 배합업체들이 동물의 저항력을 높이는 혁신적인 첨가물을 찾는 가운데, 플라보포스폴리폴의 세균 조절 및 장내 환경 개선이라는 독자적인 이중 작용이 점점 더 널리 받아들여지고 있습니다. 그 결과, 전 세계 가금류, 돼지, 수산양식 분야에서 그 채택이 확대되고 있으며, 글로벌 공급망 내에서 플라보포스폴리폴의 중요한 역할이 더욱 강화되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 플라보포스폴리폴 시장 규모 : 형태별
세계의 플라보포스폴리폴 시장 규모 : 가축별
세계의 플라보포스폴리폴 시장 규모 : 용도별
세계의 플라보포스폴리폴 시장 규모 : 유통 채널별
세계의 플라보포스폴리폴 시장 규모 : 지역별
세계의 플라보포스폴리폴 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.10.02Global Flavophospholipol Market size was valued at USD 195.0 Million in 2024 and is poised to grow from USD 204.55 Million in 2025 to USD 299.93 Million by 2033, growing at a CAGR of 4.9% during the forecast period (2026-2033).
Flavophospholipol is a key antimicrobial feed additive driving growth in the global animal nutrition market by enhancing livestock efficiency and disease resistance. This growth is fueled by increasing consumer demand for protein-rich foods, prompting producers to boost herd productivity while reducing antibiotic reliance. Regulatory shifts, particularly in the European Union, have led to a rise in flavophospholipol adoption as a viable alternative to traditional growth promoters. Its growing use in markets like the United States and Brazil for swine and poultry underscores its importance in addressing food security challenges. Additionally, the additive's acceptance reinforces its positioning as a safe substitute for banned antibiotics, encouraging innovations in formulation technologies that improve bioavailability and reduce costs, leading to better feed conversion ratios and profitability for producers.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flavophospholipol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Flavophospholipol Market Segments Analysis
Global flavophospholipol market is segmented by form, livestock, application, distribution channel and region. Based on form, the market is segmented into Powder and Premix. Based on livestock, the market is segmented into Poultry, Swine, Cattle and Others. Based on application, the market is segmented into Growth Promotion, Feed Efficiency and Disease Prevention. Based on distribution channel, the market is segmented into Feed Manufacturers, Veterinary Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Flavophospholipol Market
The rising awareness surrounding antimicrobial resistance is prompting livestock producers to explore alternative growth promoters, positioning flavophospholipol as an effective solution that enhances animal health without compromising product safety. This encourages greater acceptance in various sectors, including poultry, swine, and cattle. The growing confidence among veterinarians and feed manufacturers leads to stronger integration within the supply chain, resulting in an increased formulation of feed additives that contain flavophospholipol. This trend not only drives market penetration but also supports continuous growth, aligning with consumer preferences for safer meat products and contributing to the long-term expansion of the market.
Restraints in the Global Flavophospholipol Market
In the global market for flavophospholipol, a significant restraint arises from increasingly stringent regulations aimed at controlling antibiotic residues in food products. These regulations lead to more rigorous monitoring and lower permissible residue limits, consequently raising compliance costs for producers. Such oversight can restrict the quantity of flavophospholipol added to feed, especially in regions with strict zero-tolerance policies. As a result, many manufacturers are turning to alternative additives that are viewed as less risky, which may hinder market growth and slow the broader acceptance of flavophospholipol in various global markets.
Market Trends of the Global Flavophospholipol Market
The Global Flavophospholipol market is increasingly driven by the trend of preventive nutrition, as manufacturers highlight its efficacy in enhancing feed efficiency while reducing disease incidence without the use of therapeutic antibiotics. This focus responds to the industry's commitment to antimicrobial stewardship and aligns with farmers' desires for sustainable farming practices. As feed formulators seek innovative additives that bolster animal resilience, flavophospholipol's unique dual action on bacterial modulation and gut health is becoming more widely accepted. Consequently, its integration is expanding across poultry, swine, and aquaculture sectors worldwide, reinforcing its critical role within global supply chains.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Flavophospholipol Market Size by Form & CAGR (2026-2033)
- Market Overview
- Powder
- Premix
Global Flavophospholipol Market Size by Livestock & CAGR (2026-2033)
- Market Overview
- Poultry
- Swine
- Cattle
- Others
Global Flavophospholipol Market Size by Application & CAGR (2026-2033)
- Market Overview
- Growth Promotion
- Feed Efficiency
- Disease Prevention
Global Flavophospholipol Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Feed Manufacturers
- Veterinary Distributors
- Others
Global Flavophospholipol Market Size by Region & CAGR (2026-2033)
- Market Overview
- North America
- Europe
- Asia-Pacific
- Others
Global Flavophospholipol Market Size & CAGR (2026-2033)
- North America (Form, Livestock, Application, Distribution Channel, Region)
- US
- Canada
- Europe (Form, Livestock, Application, Distribution Channel, Region)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Form, Livestock, Application, Distribution Channel, Region)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Form, Livestock, Application, Distribution Channel, Region)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Form, Livestock, Application, Distribution Channel, Region)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Huvepharma AD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elanco Animal Health Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zoetis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Phibro Animal Health Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Virbac S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetoquinol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dechra Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HIPRA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biochem Zusatzstoffe Handels- und Produktionsgesellschaft mbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kemin Industries, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EW Nutrition GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novus International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ADM Animal Nutrition
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cargill, Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nutreco N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orffa International Holding B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Provimi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
